Skip to main content
. 2021 Aug 24;28(3):434–446. doi: 10.1093/ibd/izab193

Figure 3.

Figure 3.

The Th1, Th2, and IL-23 pathway downregulation was enriched in responders post-treatment with TL1A. Pathway analysis was performed using IPA with a significance cutoff |z score| >2. Abbreviations: IL, interleukin; IPA, Ingenuity Pathway Analysis; TL1A, tumor necrosis factor-like ligand 1A.